Abstract: |
Transport, preparation, administration, and imaging of radiopharmaceuticals inevitably results in low, but non-zero, radiation doses to personnel as well as patients and are thus subject to federal, state and local regulations. Table 3.1 summarizes the relevant regulatory agencies and the scope of their regulatory oversight. These agencies specify records that must be kept and procedures that must be followed to ensure the safe handling of these agents. Such regulatory oversight is not intended to extend to the actual practice of medicine; for example, there is no regulation limiting the administered activity of a radiopharmaceutical prescribed for a patient, as prescription of this activity is considered part of medical practice. © Springer Nature Switzerland AG 2021. |